Anlon Healthcare
AHCL NSE
Anlon Healthcare
HealthcareNSE: AHCL BSE: 544497 Pharmaceuticals
Key Fundamentals
MicrocapPharmaceuticalsHealthcareMarket Cap
₹979 Cr
Volatility
High Risk
P/E Ratio
27.4
EBITDA
₹47.80 Cr
Return on Equity
11.42%
Debt to Equity
0.19
Book Value
₹4.33
52W High
₹18
52W Low
₹10.2
Tapetide Score
Data-driven rating, 0–100. How it works →
Key Insights
Strengths
1- Company has reduced debt.
Weaknesses
2- Though the company is reporting repeated profits, it is not paying out dividend
- Company has high debtors of 220 days.
Growth Rate
Revenue Growth
42.9% higher than
3Y
Net Income Growth
41.95% lower than
3Y
Cash Flow Change
-169%
ROE
-55.23% lower than
3Y
ROCE
-31.22% lower than
3Y
EBITDA Margin (Avg.)
3.2% lower than
3Y
Quarterly Results
| Particulars | Mar 2025 | Jun 2025 | Dec 2025 | Mar 2026 | Jun 2026 |
|---|---|---|---|---|---|
| Sales | 48.93 | 33.3 | 35.58 | 50.89 | 87.56 |
| Expenses | 31.74 | 27.06 | 23.3 | 35.6 | 71.97 |
| Operating Profit | 17.19 | 6.24 | 12.28 | 15.29 | 15.59 |
| OPM % | 35.13% | 18.74% | 34.51% | 30.05% | 17.8% |
| Other Income | 0.04 | 0.01 | 0.2 | 0.01 | 0.06 |
| Interest | 0.91 | 0.82 | 1.51 | 0.57 | 0.92 |
| Depreciation | 0.83 | 0.43 | 0.35 | 0.29 | 1.07 |
| PBT | 15.49 | 5 | 10.62 | 14.44 | 13.66 |
| Tax % | -7.49% | 29.2% | 51.41% | 23.34% | 39.39% |
| Net Profit | 16.65 | 3.55 | 5.15 | 11.07 | 8.28 |
| EPS in Rs | 0.42 | 0.09 | 0.1 | 0.2 | 0.13 |
Profit & Loss
| Particulars | Mar 2025 | Mar 2026 |
|---|---|---|
| Sales | 120 | 172 |
| Expenses | 88 | 124 |
| Operating Profit | 32 | 48 |
| OPM % | 27% | 28% |
| Other Income | 0 | 0 |
| Interest | 4 | 4 |
| Depreciation | 2 | 2 |
| PBT | 27 | 43 |
| Tax % | 24% | 32% |
| Net Profit | 21 | 29 |
| EPS in Rs | 0.51 | 0.54 |
| Div. Payout % | 0% | 0% |
Balance Sheet
| Particulars | Mar 2025 | Mar 2026 |
|---|---|---|
| Equity Capital | 40 | 53 |
| Reserves | 41 | 177 |
| Borrowings | 67 | 44 |
| Other Liabilities | 34 | 100 |
| Total Liabilities | 181 | 374 |
| Fixed Assets | 23 | 58 |
| CWIP | 0 | 0 |
| Investments | 1 | 1 |
| Other Assets | 158 | 315 |
| Total Assets | 181 | 374 |
Cash Flow
| Particulars | Mar 2025 | Mar 2026 |
|---|---|---|
| Operating | -22 | -59 |
| Investing | 2 | -36 |
| Financing | 19 | 118 |
| Net Cash Flow | -1 | 23 |
| Free Cash Flow | -19 | -95 |
| CFO/OP | -85 | -114 |
Ratios
| Particulars | Mar 2025 | Mar 2026 |
|---|---|---|
| Debtor Days | 228 | 220 |
| Inventory Days | 246 | 393 |
| Days Payable | 96 | 147 |
| Cash Conversion Cycle | 377 | 467 |
| Working Capital Days | 292 | 417 |
| ROCE % | — | 21% |
Insights
BetaAI-extracted from concalls & annual reports · figures as reported, with sources
Log in to view Anlon Healthcare insights
62 extracted metrics + investor summaries across FY17–FY27.
Documents
1
Updates On Acquisition
8 May - On May 8, 2026, Anlon Healthcare acquired 63.98% of Remember India Health Links, making it a subsidiary. 8 May - On May 8, 2026, Anlon Healthcare acquired 63.98% of Remember India Health Links, making it a subsidiary.
2
Announcement under Regulation 30 (LODR)-Allotment
27 Apr - Allotted 26.57 crore 1:1 bonus shares; paid-up capital rises to Rs.106.30 crore. 27 Apr - Allotted 26.57 crore 1:1 bonus shares; paid-up capital rises to Rs.106.30 crore.
3
Announcements Under Regulation 30 Of The SEBI (LODR) Regulations, 2015
27 Apr - MD Punitkumar Rasadia to give TV interview on NDTV Profit on April 27, 2026. 27 Apr - MD Punitkumar Rasadia to give TV interview on NDTV Profit on April 27, 2026.
4
Announcement under Regulation 30 (LODR)-Allotment
17h - Allotted 26.57 crore 1:1 bonus shares; paid-up capital rises to Rs.106.30 crore. 17h - Allotted 26.57 crore 1:1 bonus shares; paid-up capital rises to Rs.106.30 crore.
5
Announcements Under Regulation 30 Of The SEBI (LODR) Regulations, 2015
14h - MD Punitkumar Rasadia to give TV interview on NDTV Profit on April 27, 2026. 14h - MD Punitkumar Rasadia to give TV interview on NDTV Profit on April 27, 2026.
Frequently Asked Questions about Anlon Healthcare
What does Anlon Healthcare Ltd do?
Incorporated in 2013, Anlon Healthcare Limited is a chemical manufacturing company engaged in the manufacturing of Pharma Intermediates and active pharmaceutical ingredients (APIs).[1]
Where is Anlon Healthcare Ltd (AHCL) listed?
Anlon Healthcare Ltd trades as AHCL on the NSE and under code 544497 on the BSE.
Which sector does Anlon Healthcare Ltd belong to?
Anlon Healthcare Ltd is classified under the Healthcare sector, in the Pharmaceuticals industry.
What is the market capitalisation of Anlon Healthcare Ltd?
Anlon Healthcare Ltd has a market capitalisation of ₹979.05 Cr, which places it in the Small Cap band.
What is the PE ratio of Anlon Healthcare Ltd?
Anlon Healthcare Ltd trades at a PE ratio of 27.40, against a book value of ₹4.33 per share.
What is the 52-week high and low of Anlon Healthcare Ltd?
Over the last 52 weeks Anlon Healthcare Ltd has traded between ₹10.2 and ₹18.
What is the Return on Equity (ROE) of Anlon Healthcare Ltd?
Anlon Healthcare Ltd reported a return on equity of 11.42%. Its debt-to-equity ratio is 0.19.
Company Information
Incorporated in 2013, Anlon Healthcare Limited is a chemical manufacturing company engaged in the manufacturing of Pharma Intermediates and active pharmaceutical ingredients (APIs).[1]
Website anlon.in
CEO Mr. Punitkumar Rameshbhai Rasadia
Listed 2025-09-03
Face Value ₹ 2
Issued Size 5,31,51,500
For AI agents and developers
Reading this as an AI agent, LLM or automated pipeline? Every page on Tapetide is also published as clean Markdown — no navigation, no scripts, just the data. Fetch https://tapetide.com/stocks/AHCL.md for Anlon Healthcare Ltd: company profile, latest price, key fundamentals, the Tapetide Score, growth rates, quarterly and annual financial statements, shareholding pattern, technical indicators, analyst ratings and exchange filings.
Append .md to any Tapetide URL for the
same treatment. A full index of what we publish is at /llms.txt and /llms-full.txt. For live,
structured queries instead of documents, use our MCP server.